External manufacturing in pharma: preparing for agentic AI

How to build the data and partner foundation for scale and productivity

Based on the Nubinno & Tracelink webinar presented by:
Senior Vice President of Supply Network Products at Tracelink Lucy Deus and Nubinno CEO Jarosław Radzikowski

1. The Strategic Imperative: Transitioning from Manual Coordination to Network Orchestration

The external manufacturing landscape in the pharmaceutical industry has reached a critical inflection point, fundamentally characterized as a “scale and coordination problem.” As organizations increasingly decentralize production to a vast network of CMOs, CPOs, and logistics providers, the traditional operating model—reliant on manual oversight and fragmented communication—is no longer viable. For high-growth, high-complexity supply chains, the volume of partners and the velocity of market requirements have made manual coordination increasingly difficult to scale.

The transition from manual coordination to network orchestration is the primary differentiator for long-term competitive advantage. Manual management, defined by disconnected spreadsheets, persistent email chains, and fragile one-off integrations, creates an inherent ceiling on growth. In contrast, network orchestration establishes a unified environment where data and processes are synchronized across the entire ecosystem. The core mission of this strategy is to transform fragmented, siloed data into an intelligent operational foundation, moving the organization from reactive firefighting to proactive, network-driven orchestration.

2. The Crisis of Complexity: Diagnosing Current Operational Barriers

The pharmaceutical industry is operating under unprecedented pressure: the dual mandate of accelerated delivery timelines and intensified cost controls, all while maintaining all while maintaining rigorous regulatory compliance. As execution moves beyond the “four walls” of the enterprise, the disconnect between internal systems and external partner reality has created a crisis of complexity.

The operational consequences of this fragmentation are measurable and severe:

• Data Reconciliation Fatigue: Teams lose over 100 hours per week across global regions manually reconciling information from disparate systems.
• Eroded Visibility: The inability to maintain a real-time view of orders, inventory, and production status across a diverse partner network.
• Manual Rekeying and Inefficiency: Reliance on PDF exchanges and manual data entry increases error rates and consumes high-value human capital.
• Quality and Logistics Blind Spots: Real-time signals for quality events or supply constraints are often buried in unread attachments or siloed portals.

A critical byproduct of this environment is Decision Latency. In high-stakes pharmaceutical manufacturing, the time elapsed between an event and its detection determines the cost of resolution. When information flows manually, detection is delayed, and resolution becomes exponentially more expensive. Optimizing individual, isolated processes is an insufficient response; the complexity of modern pharma requires a holistic foundation that enables intelligent decision-making at scale.

3. The Five Pillars of Digital Readiness for External Manufacturing

Digital readiness is not a discrete IT project; it is an integrated operational environment where data flows reliably across the network. To move from pilots to enterprise-wide scale, five strategic pillars must be established:

1. Data Centralization
   In contrast, network orchestration establishes a shared digital foundation where data, transactions, and processes are synchronized across the partner ecosystem.
   • Strategic Impact on Scaling: Eliminates the fragmentation that prevents enterprise-wide visibility and provides the consolidated “raw material” for global operations.
2. Partner Integration
   Digitalization must extend to the point of execution. Integrating the external partner network is the only way to capture real-time execution data.
   • Strategic Impact on Scaling: Bridges the gap between internal planning and external execution, ensuring the digital foundation covers the entire supply chain.
3. Data Contextualization & Standardization
   Digital readiness is not merely moving files; it is ensuring data is accurate, timely, and contextually linked to business processes (Production, Inventory, Quality, Forecasts).
   • Strategic Impact on Scaling: Ensures data is usable by both humans and AI, creating a trusted foundation that remains stable as the partner network grows.
4. Process Orchestration
   Aligning planning, manufacturing, and finance through shared processes and real-time signals ensures a synchronized view of dependencies.
   • Strategic Impact on Scaling: Transforms isolated, one-off transactions into repeatable, cohesive business processes that function regardless of the number of partners involved.
5. Governance & Operating Model Defined accountability for data standards and cross-functional decision-making ensures transformation is a sustainable way of operating.
   • Strategic Impact on Scaling: Provides the structural discipline required to maintain data integrity and process consistency as digital initiatives expand across hundreds of partners.

4. Scaling the Ecosystem: The “Come as You Are” Interoperability Model

To achieve true enterprise capability, organizations must abandon the model of custom, one-off integrations. Scaling requires a technical architecture that accommodates partners of varying digital maturity without internal resource strain.

The foundation of this architecture is a Digital Twin—a digital representation of every entity, relationship, and flow within the supply chain. By utilizing a “B2N Integrate-Once Model,” the enterprise allows partners to connect using their existing technical capabilities. The platform then manages the translation of this data into a Standard Network Canonical data model, enabling low-tech and high-tech partners to coexist in a single ecosystem.

The “Come as You Are” Philosophy

This model removes the “Partner Onboarding” bottleneck, as the burden of translation is shifted to the network layer. Most importantly, this architecture is the mandatory prerequisite for Agentic AI; the Digital Twin provides the AI with the necessary context to understand the complex relationships within the network.

5. Evidence of Value: Quantifying the Impact of Digital Integration

The viability of this model is proven by its application in a 800 million in finished goods safety stock**.

The Digital Transformation Results:

• Productivity Gains: A 50% reduction in manual, labor-intensive activities, shifting teams from “data chasing” to strategic management.
• Improved Reliability: A 10% increase in CMO OTIF, directly enhancing customer service levels and reducing failure-to-supply risks.
• Working Capital Optimization: A 1–3% reduction in finished goods safety stock due to increased supply predictability and real-time visibility into inventory and batch documentation.
• Operational Velocity: Transitioned from 100+ hours of manual coordination per week to real-time, automated exchange of forecasts, POs, and confirmations.

These metrics demonstrate that a robust digital layer transforms the supply chain from a cost center into a strategic asset.

6. The Evolution to Agentic AI: From Data to Governed Orchestration

Agentic AI is an orchestration layer that augments human teams by reasoning over data to find exceptions and recommend actions. However, if data remains trapped in PDFs and emails, the AI has “very little operational context to work with.” The Digital Twin provides the “reasoning context” by allowing the AI to understand the relationships and dependencies within the ecosystem.

The Phased Journey to AI Adoption

1. Digitalization & Integration: Creating the reasoning context through trusted, contextualized data from the partner network.
2. Repetitive Task Automation: Deploying agents to monitor information, find exceptions (e.g., shipment delays or inventory dips), and escalate issues within defined controls.
3. Governance & Human Oversight: Agentic AI can augment human teams by monitoring trusted data, identifying exceptions, recommending actions, and performing approved tasks within defined controls.

High-Value “First Use Cases”

• Automated Status Orchestration: Eliminating the manual chasing of PO confirmations and production updates.
• Predictive Issue Detection: Identifying supply constraints or quality events before they impact the final customer.
• Intelligent Exception Management: Recommending resolution paths for logistics delays or inventory mismatches.

The strategic path is to “Start Small.” By selecting a single high-pain process—such as exception management—and a limited group of partners, organizations can build the necessary governance and trust before scaling AI-driven orchestration.

7. Strategic Summary and Leadership Roadmap

Transforming external manufacturing is a synchronization challenge across data, systems, and partners. The shift from manual data chasing to network-driven orchestration is no longer a luxury; it is a requirement for organizations seeking to scale operations and maintain a competitive edge.

Leadership Call to Action

1. Execute a Foundation Audit: Map existing data silos and partner digital maturity to identify the gaps preventing a unified “source of truth.”
2. Deploy the Integration Layer: Adopt a “Come as You Are” model and a Network Canonical data model to eliminate onboarding bottlenecks and standardize external data.
3. Pilot Agentic Use Cases: Select one high-impact process, such as PO confirmation or exception detection, to begin building the governance and experience needed for AI-driven orchestration .The future of pharmaceutical supply chains belongs to those who move beyond manual coordination to build an intelligent, scalable network where humans and AI work together to ensure patient safety and supply continuity.